+499.5%
MRNA vs HAS
+20.3%
+479.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.5% | -1.7% | -2.2% |
| 7D | +5.5% | -1.8% | +7.3% | +5.7% |
| 30D | +158.7% | +2.3% | +156.5% | +158.0% |
| 3M | +182.1% | +10.4% | +171.8% | +178.9% |
| 6M | +151.8% | -3.2% | +155.1% | +154.8% |
| YTD | +393.6% | +15.4% | +378.1% | +362.8% |
| 1Y | +499.5% | +18.8% | +480.7% | +475.1% |
| All | +499.5% | +20.3% | +479.1% | +475.1% |
Cumulative growth
Daily Returns
Daily percentage return beside HAS.
Daily Out/Under-Performance
Portfolio return minus HAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling